Di Li Sheng Uses, Dosage, Side Effects and more
Di Li Sheng has been used in trials studying the treatment of Bronchiectasis, Cystic Fibrosis, Pulmonary Alveolar Proteinosis, Acute Respiratory Distress Syndrome, and Autoimmune Pulmonary Alveolar Proteinosis.
| Trade Name | Di Li Sheng |
| Generic | Molgramostim |
| Molgramostim Other Names | Molgramostim |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | China |
| Last Updated: | January 7, 2025 at 1:49 am |
